Real-World Treatment Patterns of Glucose-Lowering Agents Among Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease or At Risk for Cardiovascular Disease: An Observational, Cross-Sectional, Retrospective Study.

Content Provider	Europe PMC
Author	Nair, Radhika Mody, Reema Yu, Maria Cowburn, Stuart Konig, Manige Prewitt, Todd
ISSN	18696953
Journal	Diabetes Therapy
Volume Number	13
PubMed Central reference number	PMC9663782
Issue Number	11-12
PubMed reference number	36131064
e-ISSN	18696961
DOI	10.1007/s13300-022-01320-1
Language	English
Publisher	Springer Healthcare
Publisher Date	2022-09-21
Publisher Place	Cheshire
Access Restriction	Open
Rights License	Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/. © The Author(s) 2022
Subject Keyword	Type 2 diabetes Cardiovascular disease Sodium-glucose co-transporter-2 inhibitors Glucagon-like peptide-1 receptor agonists Treatment patterns
Content Type	Text
Resource Type	Article
Subject	Endocrinology, Diabetes and Metabolism Internal Medicine